MICROTECH MED-B (02235.HK): Full Circulation of 250 Million H Shares
On 6 November 2026, MICROTECH MED-B said the Exchange approved listing of 250,087,968 H shares under full circulation on 5 November, pending conditions.
Key Highlights:
- The Exchange approved the listing and trading of 250,087,968 converted H shares on 5 November 2026, subject to conditions.
- The shares correspond to the CSRC's October 2026 filing notice for full circulation of unlisted shares.
NewTimeSpace News: On 6 November 2026, MicroTech Medical (Hangzhou) Co., Ltd. (Stock Code: 2235) announced under Rule 13.09(2)(a) and Part XIVA of the SFO that the Stock Exchange approved on 5 November 2026 the listing and trading of 250,087,968 H shares, subject to other conditions.
The announcement shows that the CSRC had issued a filing notice in October 2026 for the full circulation of 250,087,968 unlisted shares, including domestic and unlisted foreign shares. Of the 421,078,000 issued shares, H shares of 169,175,842 represented about 40.1768% and unlisted shares of 251,902,158 about 59.8232%. After completion, H shares will rise to 419,263,810, or about 99.5692%, and unlisted shares will fall to 1,814,190, or about 0.4308%.
- MICROTECH MED-B (02235.HK): Next-generation CGM AiDEX G9 obtains NMPA registration approval for marketing
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- ETF Financing Ranking | Bosera NASDAQ 100 ETF(QDII) (513390) had a net financing buy-in of CNY 33.91 million, ranked first among comparable funds
- ETF Financing Ranking | Bosera NASDAQ 100 ETF(QDII) (513390) had a net financing buy-in of CNY 21.11 million on Jul 27, ranked top among comparable funds
